Essentials: Nicotine's Effects on the Brain & Body & How to Quit Smoking or Vaping
Andrew Huberman explains how nicotine affects the brain and body by increasing dopamine, acetylcholine, and norepinephrine, while emphasizing the importance of separating nicotine's pharmacological effects from harmful delivery methods like smoking and vaping. The transcript covers nicotine's cognitive benefits, addiction mechanisms, and evidence-based cessation strategies including hypnosis and pharmacological interventions.
Summary
Andrew Huberman begins by distinguishing nicotine as a substance from its delivery methods, noting that nicotine receptors naturally exist in human brains and are not merely artifacts of tobacco or vaping devices. Nicotine exists naturally in nightshade vegetables like tomatoes and eggplants. The substance works by binding to nicotinic acetylcholine receptors, primarily the alpha-4 beta-2 receptor subtype.
Huberman outlines three major neurochemical pathways activated by nicotine: First, it triggers dopamine release in the nucleus accumbens via the mesolimbic reward pathway, creating feelings of well-being, alertness, and motivation. This dopamine pathway is the primary reason nicotine is reinforcing and addictive. Second, nicotine increases acetylcholine release from the nucleus basalis, acting as a neurochemical spotlight that enhances focus and concentration for approximately 30-45 minutes. Third, it increases norepinephrine from the locus coeruleus, promoting alertness and arousal. Combined, these effects create an optimal state for cognitive work: mental alertness paired with physical relaxation.
Additionally, nicotine suppresses appetite by activating POMC neurons in the hypothalamus and increases metabolism by 2-5% transiently. It also increases heart rate, blood pressure, and heart contractility while somewhat relaxing skeletal muscle.
Regarding delivery methods, smoking and vaping cause significant health damage not from nicotine itself but from other compounds and endothelial cell damage. Cigarettes contain 4,000-7,000 toxins including tar, ammonia, formaldehyde, and carbon monoxide—all carcinogens. Smoking is estimated to reduce lifespan by 14 years per pack per day. Dipping causes a 50-fold increase in mouth cancers. Vaping resembles crack cocaine in its rapid onset of nicotine delivery to the bloodstream, which makes it more habit-forming than cigarette smoking—the speed of dopamine increase, not just peak levels, determines addiction potential. This explains why vaping is harder to quit than smoking and is associated with increased depression rates.
Huberman recommends avoiding nicotine entirely for people under 25 years old due to ongoing brain development. For adults 25 and older, occasional nicotine use in non-smoking/non-vaping forms might provide cognitive benefits, though he explicitly discourages smoking, vaping, dipping, and snuffing.
Withdrawal from nicotine begins within 4 hours and involves dopamine dropping below baseline—this drop is what causes craving, a specific biological mechanism rather than merely psychological. The first week is critical for cessation, with 75% of people relapsing within this period.
Huberman discusses evidence-based cessation methods: Clinical hypnosis developed by Dr. David Spiegel at Stanford achieves 23% success rates (compared to 5% cold-turkey success), and bupropion increases success to approximately 20%. Nicotine replacement therapy using patches, gum, and nasal sprays can be effective when rotated weekly to prevent homeostatic adaptation. Healthy dopamine-boosting alternatives during cessation include cold exposure, exercise, and positive social interaction. Monthly or weekly hypnosis sessions after quitting help maintain abstinence. Alcohol consumption significantly increases relapse risk.
Key Insights
- Nicotine binds to naturally occurring nicotinic receptors in the brain that did not evolve because of tobacco or vaping but have important roles in normal brain and body function, meaning the receptors predate the delivery devices by millions of years
- The speed of dopamine increase in the mesolimbic pathway, not just the peak amount, is the critical determinant of how addictive and habit-forming a substance is, which is why vaping causes faster dopamine onset and is more addictive than cigarette smoking
- Clinical hypnosis developed at Stanford achieves a 23% success rate for smoking cessation with a single session, compared to only 5% success for people attempting to quit without assistance
- Nicotine itself is not a carcinogen and does not cause cancer; rather, the 4,000-7,000 toxins in cigarettes (tar, ammonia, formaldehyde, carbon dioxide) and endothelial cell damage from delivery methods are responsible for cancer and health damage
- During nicotine withdrawal, dopamine drops below baseline rather than simply returning to normal levels, causing withdrawal symptoms worse than pre-use state, which is why 75% of people relapse within the first week
Topics
Transcript
[0:00] Welcome to Huberman Lab Essentials, [music] where we revisit past episodes for the most potent and actionable science-based [music] tools for mental health, physical health, and performance. I'm Andrew Huberman, and I'm a professor of neurobiology and opthalmology at Stanford School of Medicine. Today we are discussing nicotine. Nicotine is one of the most commonly consumed substances on the entire planet. Today we are going to separate our discussion of nicotine from a discussion of smoking and vaping and the other forms of delivery for [0:30] nicotine. We will be talking about smoking and vaping and other routes of nicotine administration both for sake of highlighting their detriments to health and believe it or not in certain cases keep…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Andrew Huberman
Mushrooms for the Mind & Immune System | Paul Stamets
Paul Stamets discusses the therapeutic and immunological potential of fungi, including non-psychedelic mushrooms for immune enhancement and cognitive function, as well as psilocybin mushrooms for treating depression, PTSD, and OCD. He presents clinical research on mushroom extracts enhancing vaccine efficacy and explores the broader role of fungal networks in planetary health and human consciousness.
Essentials: How Emotions & Social Factors Impact Learning | Dr. Mary Helen Immordino-Yang
Dr. Mary Helen Immordino-Yang discusses how emotions, embodiment, and storytelling are fundamental to learning and human consciousness. She argues that inspiration and awe activate basic survival mechanisms through narrative meaning-making, and that current education systems suppress natural curiosity by focusing on performance metrics rather than genuine intellectual engagement and personal development.
Why Addiction is a Control Problem | Dr. Anna Lembke
Dr. Lembke argues that severe addiction is fundamentally about the desire for control rather than substance dependence. She explains that humans constantly predict outcomes in the world, and when predictions fail, they either update their mental model or attempt to control/reshape the world itself to reduce uncertainty.
Breaking the Codependency Cycle | Dr. Anna Lembke
Dr. Anna Lembke explains that when a codependent person in a family stops enabling and focuses on their own recovery through programs like Alanon, the dependent person often naturally moves toward recovery themselves. This dynamic mirrors a rope-pulling metaphor where releasing tension paradoxically resolves the stalemate.
Overcome Addictions and Obsessions of All Kinds | Dr. Anna Lembke
Dr. Anna Lembke discusses the neurobiology of addiction, emphasizing that severe addiction is fundamentally about control rather than substance use itself. She introduces the concept of 'radical surrender'—relinquishing attempts to control outcomes—as essential to recovery, and explores how spiritual practices activate different brain networks that enable escape from addictive cycles.